Adaptimmune Therapeutics plc (ADAPY)
OTCMKTS · Delayed Price · Currency is USD
0.0310
+0.0075 (31.91%)
At close: Nov 19, 2026
Adaptimmune Therapeutics Market Cap
Adaptimmune Therapeutics has a market cap or net worth of $8.22 million as of November 19, 2026. It is the 43,634th most valuable company in the world and the 5,753rd biggest in the United States. Its market cap has decreased by 45.61% in one year.
Market Cap
8.22M
Enterprise Value
-3.65M
Revenue
5.92M
Global Rank
Country Rank
#5,753 United States
PE Ratio
0.39
ChartMarket Cap Chart
Since May 7, 2015, Adaptimmune Therapeutics's market cap has decreased from 1.22B to 8.22M, a decrease of -99.33%. That is a compound annual growth rate of -35.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2026 | 8.22M | 19.23% |
| Dec 31, 2025 | 6.89M | -95.00% |
| Dec 31, 2024 | 137.84M | -23.47% |
| Dec 29, 2023 | 180.11M | -24.70% |
| Dec 30, 2022 | 239.19M | -59.17% |
| Dec 31, 2021 | 585.77M | -29.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Inhibitor Therapeutics | 13.90M |
| Synlogic | 13.47M |
| Brainstorm Cell Therapeutics | 12.56M |
| Anebulo Pharmaceuticals | 11.42M |
| Hepion Pharmaceuticals | 11.30M |
| Curative Biotechnology | 7.56M |
| TRON Group | 6.42M |
| Zeo ScientifiX | 6.24M |